Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs such as morphine into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers. Pain Therapeutics has a market cap of $232.7 million; its shares were traded at around $5.18 with a P/E ratio of 19.8 and P/S ratio of 3.6.
Recent Trades of Pain Therapeutics by CEO:
- Sell: CEO, 10% Owner Remi Barbier sold 23,200 shares of PTIE stock on 09/11/2009 at the average price of $5.23; the price of the stock has decreased by 0.96% since.
- Sell: President and CEO, 10% Owner Remi Barbier sold 50,000 more shares of PTIE stock on 06/05/2009 at the average price of $5.26; the price of the stock has decreased by 1.52% since.
- Sell: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 26,800 more shares of PTIE stock on 05/16/2009 at the average price of $5.23; the price of the stock has decreased by 0.96% since.
Recent Trades of Pain Therapeutics by CFO:
- Buy: Vice President & CFO Peter S Roddy bought 3,374 shares of PTIE stock on 05/01/2009 at the average price of $3.77; the price of the stock has increased by 37.4% since.
- Sell: CFO Peter S Roddy sold 40,000 shares of PTIE stock on 08/31/2009 at the average price of $5.08; the price of the stock has increased by 1.97% since.
Recent Trades of Pain Therapeutics by Directors and Officers:
- Buy: COO Nadav Friedmann bought 3,374 shares of PTIE stock on 05/01/2009 at the average price of $3.77; the price of the stock has increased by 37.4% since.
- Sell: 10% Owner Capital Management Eastbourne sold 3,076,915 shares of PTIE stock on 09/29/2009 at the average price of $4.98; the price of the stock has increased by 4.02% since.
- Sell: 10% Owner Capital Management Eastbourne sold 1,663,000 more shares of PTIE stock on 08/07/2009 at the average price of $3.96; the price of the stock has increased by 30.81% since.
- Sell: 10% Owner Capital Management Eastbourne sold 90,778 more shares of PTIE stock on 07/14/2009 at the average price of $4.23; the price of the stock has increased by 22.46% since.
- Sell: 10% Owner Capital Management Eastbourne sold 368,000 more shares of PTIE stock on 07/07/2009 at the average price of $4.58; the price of the stock has increased by 13.1% since.
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |